Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
about
Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.Epidemiology and treatment approaches in management of invasive fungal infectionsInhaled therapeutics for prevention and treatment of pneumoniaMinimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy.Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex.Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
P2860
Q33764269-5FE77B90-4145-4E7E-96CE-92E956F0DAD2Q34301513-1D9C5F1A-F194-46E0-A151-6F9D7DBEB2F3Q35089772-BFE01F97-41F7-448A-A815-D4097567D213Q35925366-1BECC719-3797-4796-BFA0-BF2E4CFCB2C7Q36867435-1721955E-AF12-430C-BF1A-D0949E9FDDB1Q37641383-CE488416-54A4-49EB-93F4-4D3F1421D6C5Q37816399-373F7979-B05B-401A-AA03-D5F3FA057922Q37866827-E65F9F8F-FD52-4F40-9091-1BD9E355B8D7Q37925817-C76EF4ED-35B7-4162-B213-FF7EF1434556Q38077678-225381E4-D1C0-42FB-BFF0-F47ADB576E3DQ41712164-9760A4D5-67D6-4834-BEBC-80F7413B5033Q44558731-E9017CC8-5F37-4609-A35B-0A8A91A84624Q46089515-37AE0E1D-5E3F-4E6C-8316-206FEFF517A2
P2860
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Amphotericin B lipid complex a ...... rgoing induction chemotherapy.
@en
type
label
Amphotericin B lipid complex a ...... rgoing induction chemotherapy.
@en
prefLabel
Amphotericin B lipid complex a ...... rgoing induction chemotherapy.
@en
P2093
P2860
P50
P356
P1433
P1476
Amphotericin B lipid complex a ...... rgoing induction chemotherapy.
@en
P2093
Alexandra Ferrajoli
Deborah Thomas
Dimitrios Kontoyiannis
Elihu Estey
Gloria N Mattiuzzi
Isaam Raad
Nebiyou Bekele
P2860
P304
P356
10.1002/CNCR.11936
P407
P577
2004-02-01T00:00:00Z